Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
BMS-backed Dispatch unveils with $216M, Carl June as cofounder
Dispatch's two-pronged approach has clearly impressed investors. Since 2022, the biotech has raised $216 million in both seed and series A money.
Gabrielle Masson
Jul 23, 2025 6:30am
Novartis inks $175M option deal for Sironax’s BBB tech
Jul 9, 2025 10:29am
AN Venture Partners raises $200M to boost Japan biotech industry
Jul 2, 2025 11:45am
Arch-backed tRNA biotech shutters after viewing preclinical data
Mar 18, 2025 10:15am
Arbor sails into rocky gene editing waters with $74M
Mar 18, 2025 6:30am
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
